Dynorphin (1-17) | CAS:80448-90-4

We serve Dynorphin (1-17) CAS:80448-90-4 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Dynorphin (1-17)

Chemical Name:Dynorphin (1-17)
CAS.NO:80448-90-4
Synonyms:Dynorphin (1-17)
Dynorphin A porcine
Dynorphin acetate
 
Physical and Chemical Properties:
Density 1.5±0.1 g/cm3
Molecular Formula C99H155N31O23
Molecular Weight 2147.484
Index of Refraction 1.669
 
Specification:
Appearance:White to off-white powder
Assay:≥98.0%
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Dynorphin A-( 1- 17) is an endogenous opioid derived from the prohormone prodynorphin. It acts as endogenous κ-agonist that is resistant to enzymatic degradation. And it is a neuroactive peptide with potent analgesic effects.



Contact us for information like Dynorphin (1-17) chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Dynorphin acetate physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Dynorphin (1-17) Use and application,Dynorphin (1-17) technical grade,usp/ep/jp grade.


Related News: Like other countries in Southeast Asia, Indonesia depends heavily on Chinese tourism. On Thursday alone, 10,000 Chinese tourists canceled their trips to Bali, according to one industry association.N,N-dimethylformamide manufacturer ut others aren’t convinced — they think one of the country’s most influential state media outlets could be promoting pseudoscience and false hope.1-Butaneboronic acid supplier The rigosertib Pre-approval Access Program is expected to launch in first half of 2020 and will allow Inceptua to supply intravenous rigosertib within designated countries, primarily and initially concentrated in selected countries in Europe, in response to physician requests for patients with higher-risk MDS who have exhausted all available treatment options, and are not eligible for or have no access to the INSPIRE study.5-Aminomethyl-2-chloropyridine vendor From the perspective of the corresponding formulation manufacturer, the drug substance needs to meet the requirements of impurities and stability. The production base must pass the international quality system certifications such as cGMP and EuGMP. At the same time, the drug substance company must have sufficient capacity.Since first being reported in the city of Wuhan, where it is believed to have originated at a seafood market, the virus has not provoked unusual symptoms in people who have been diagnosed.